26

Aug2016
Information Session on the PMPRB Guidelines Modernization Discussion Paper On August 23rd, 2016, PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, held a free “Information Session on the PMPRB Guidelines Modernization Discussion Paper”. This came shortly after the PMPRB recently releasing its long awaited consultation paper “PMPRB ... Read More

19

Aug2016
2015 Annual Report Released  Earlier today, the Patented Medicine Prices Review Board (PMPRB), in accordance with sections 89 and 100 of the Patent Act, released its Annual Report for the year ended December 31, 2015. The Annual Report is an extensive document that reviews all of the PMPRB’s major activities, analyses of ... Read More

12

Aug2016
*Tuesday, August 17th Webinar CANCELLED* We regret to inform you that the webinar session on Wednesday, August 17th, 2016 from 10:00 a.m. to 12:00 p.m. (noon) is cancelled due to unforeseen technical issues. We wanted to give as much notice as possible so individuals can register for the alternate date (Tuesday, ... Read More

10

Aug2016
On June 24, 2016, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”. Are you interested in learning more about the potential repercussions of these changes on Canadian drug prices and implications for pharmaceutical companies? PDCI Market Access Inc., Canada’s leading pricing and reimbursement ... Read More

05

Aug2016
Results of the Notice and Comment Period on Incremental Reforms to the Compendium of Policies, Guidelines and Procedures On December 4, 2015, the PMPRB announced the start of a Notice and Comment initiative to seek stakeholder feedback on two proposed amendments to the Compendium of Policies, Guidelines and Procedures: the “Reasonable ... Read More

29

Jul2016

SAVE THE DATE

PDCI’s PMPRB Guidelines Modernization Webinar Session On June 24, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”.  The paper, the initial phase of a three-part Guideline modernization process, asserts that PMPRB’s current framework is outdated and seeks feedback on a wide range ... Read More

21

Jul2016
Correction to the below TargetPharma (“PMPRB 2015 Annual Report”) sent out on July 21, 2016. The PMPRB report tabled in Parliament was their report with respect to the Access to Information Act and to the Privacy Act and not the anticipated “2015 PMPRB Annual Report” which was not tabled and now ... Read More

04

Jul2016
On June 24, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”.  The paper, the initial phase of a three-part Guideline modernization process, asserts that PMPRB’s current framework is outdated and seeks feedback on a wide range of issues that will inform ... Read More

27

Jun2016
Discussion Paper.  On Friday June 24, the PMPRB released a long delayed discussion paper covering a wide range of issues that go to the core of the PMPRB’s price regulation mandate.  The PMPRB will be seeking input from stakeholders over the Summer/Fall of 2016 and will hold public policy hearings ... Read More

03

May2016
The Patented Medicine Prices Review Board (PMPRB) has released its April 2016 NEWSletter. Some recent changes include: Public Consultation on PMPRB Framework Modernization In December 2015, the PMPRB released its 2015-2018 Strategic Plan, the culmination of a year-long strategic planning process that identified a new vision, a revised mission statement, and four ... Read More